Gene expression analysis provides an avenue to a wealth of information as the expression levels can shed light on various cellular processes and offer insights about the molecular underpinnings of diseases. As such, approaches for studying mRNA abundances represent a highly important and influential group of methods.

Over the years, several expression analysis methods, catering to different needs, have been developed. Some approaches are capable of analyzing a single gene (or at most a very limited number of genes), albeit at a high sample throughput. The 'gold standard' method of reverse transcription PCR (RT-PCR) falls within this category and is commonly recruited for validation purposes. At the other end of the spectrum are techniques allowing expression analysis of all transcripts. The most well-known of these global approaches relies on hybridization of a sample to DNA microarrays carrying a large number of probes corresponding to the transcripts of interest. However, microarrays suffer from cross-hybridization induced unspecificity and a rather limited dynamic range. Nevertheless, they have been widely applied to study different facets of the transcriptome over the last decade[@b1].

Currently, a group of methods collectively termed RNA-Seq, based on readout with massively parallel DNA sequencers, is being widely adopted at the expense of microarrays[@b2]. In these approaches -- originating from expressed sequence tag (EST) sequencing -- RNA is converted into a DNA library, which is sequenced and the counts of all different transcripts converted to expression levels. The benefit of sequencing-based approaches is the highly reliable digital readout and a superior dynamic range[@b3]. Additionally, the sequencing output illuminates transcript structure and reveals, for example, mutations and polymorphisms, thus further characterizing the transcriptional landscape[@b4]. However, RNA-Seq is still too cost-prohibitive to be performed more routinely. Moreover, the majority of the RNA-Seq protocols do not present the possibility to only target a subset of particularly informative RNA species. Several sequencing instruments are commercially available with Illumina, Life Technologies (both Ion Torrent and SOLiD) and 454/Roche sequencers being the most widely employed[@b5]. Moreover, there is fervent activity in developing novel sequencing approaches[@b6][@b7].

Spanning the divide between global and validation methods are intermediary techniques adapted to rapid analysis of moderate gene sets at a high throughput[@b2]. BeadsArray for the Detection of Gene Expression (BADGE) utilizing the Luminex microsphere suspension arrays[@b8], and cDNA-mediated annealing, selection, extension and ligation (DASL) marketed by Illumina[@b9] are two examples. Recently, the RNA-mediated oligonucleotide annealing, selection and ligation (RASL) method, a forerunner of the DASL technique where ligation occurs directly on RNA and the extension step is omitted, has been adapted for massive sequencing in a method dubbed RASL-seq[@b10][@b11]. Additionally, capture of RNA species of interest with readout using sequencing, in a manner akin to enrichment of selected genomic regions or exomes, has been demonstrated[@b12].

An alternative technique to the aforementioned intermediary methods is trinucleotide threading (TnT). TnT harnesses the specificity of a polymerase and a ligase, in conjunction with a restricted trinucleotide set, to faithfully amplify several genomic regions[@b13][@b14][@b15]. Briefly, the expression version of the method involves two probes that are designed to target a region specific to the transcript of interest. These anneal to mRNA-derived single-stranded cDNA in a manner creating a small gap between them. The distinguishing feature of this gap is its composition as it only entails three out of the four possible nucleotides. The concerted action of a polymerase and a ligase bridges this gap and links the two segments creating a full DNA thread. Naturally, each transcript generates one type of thread, the amount of which is dependent upon the prevalence of that transcript. To increase sensitivity, each full DNA thread carries general amplification handles enabling a parallel amplification with a single universal primer pair. All threads are of similar lengths, addressing the length bias frequently observed in PCR. The original gene expression TnT investigation entailed a thread-specific primer extension coupled with hybridization of the extension product to generic address tag arrays for readout.

Regardless of the choice of expression analysis method, it is important to consider the amount of oligonucleotides or primers (as required by the method) with the RNA input. A balanced oligonucleotide:RNA ratio allows generation of reliable expression profiles while maximizing the resources (for instance, enzymatic activity or sequencing capacity) allocated to actual transcripts, as opposed to undesired side-products such as primer-dimers.

In this study, we have used TnT in conjunction with 454 sequencing to investigate the effect of different ratios of oligonucleotides to input RNA on both the generated expression profiles and on the presence of unwanted products. The massively parallel sequencing readout enables a precise characterization of all obtained species -- both desired and undesired -- and hence clearly illuminates the outcome of the reaction. We found a direct relationship between higher oligonucleotide:RNA ratios and the occurrence of undesired products. Although the expression patterns were similar, the unwanted products used a significantly higher proportion of sequencing resources when an overabundance of oligonucleotides was employed.

Additionally, as the investigation featured a set of 32 selected genes, a combination of TnT and 454 represents a targeted RNA-Seq strategy whereby transcripts of particular interest can be enriched and analyzed in parallel against a background of the entire mRNA population. This is beneficial as only a small percentage of the about 10,000 protein-coding genes expressed at any given time displays considerable abundance differences when two samples are compared. Accordingly, targeting only these species can provide sufficient information while drastically lessening the dimensionality of the involved assays. The expression profiles obtained with TnT-454 correlate well with both TnT analyzed with an array-based strategy and with RT-PCR. However, the broad dynamic range of the 454 platform allows a reduction in input RNA requirements. Consequently, by choosing informative intermediary gene sets and barcoding transcripts from several different individuals in a combinatorial scheme[@b16][@b17] we envision TnT in combination with massively parallel sequencing platforms to enable a highly multiplexed analysis both with regard to transcript and sample number.

Results
=======

Trinucleotide threading is a method capable of multiplex amplification of genomic regions or transcripts in a single tube, while keeping the amount of spurious products to a minimum. Our previous renditions of the method have used arrays with user-selected, albeit fixed, content as readout. As such, potential undesired products went undetected. To investigate the spurious product formation, especially its extent at different oligonucleotide:RNA ratios and if it affects the obtained expression results, we adapted the TnT gene expression approach to a sequencing-based readout with the Roche/454 Genome Sequencer FLX Titanium instrument. The sequencing strategy, although more expensive than conventional arrays, offers an unbiased view of the TnT-generated product population detecting both desired and side products thereby shedding light on the events taking place during this reaction. Total RNA from two cell lines, EFO-21 and SK-MEL-30, was employed at three different oligonucleotide:RNA ratios each. The TnT oligonucleotide concentration was fixed (0.01 nM of each extension primer and 0.05 nM of each thread-joining primer), while progressively lowering the total RNA input (350 ng, 35 ng and 3.5 ng). Accordingly, two reaction triplets with gradually decreasing RNA amounts were set up.

The reactions of each triplet were individually barcoded with 454/Roche Multiplex Identifiers (MIDs), pooled and loaded into a single lane of a 454/Roche Genome Sequencer FLX Titanium picotiter plate. The sequencing reads were partitioned based on their MID sequences and subsequently BLAST-searched against a custom database comprising all potential DNA threads. True thread reads and reads aligning to two database entries were isolated and counted. Short reads, reads producing short or inferior alignments and displaying no hits were removed. The criteria for true threads were rather stringent to avoid inclusion of undesired sequences in this category and, accordingly, to enable a reliable extraction of expression profiles. Naturally, with relaxation of the parameters a greater number of reads can be classified as threads.

The statistics of the sequencing run are given in [Table 1](#t1){ref-type="table"}. On average, the EFO-21 reactions generated about 39,100 reads that passed the filtering steps. For SK-MEL-30 the corresponding read number was 61,900. The distribution of reads among the pooled samples was not even. For the EFO-21 reaction triplet (occupying the same lane in the picotiter plate), the read distribution ranged from 25.6% to 45.2% per reaction. In the case of SK-MEL-30 triplet the interval was between 27.8% and 44.3%. A plausible explanation for this is that the barcoding scheme employing 454 Multiplex Identifiers is slightly biased. For example, the efficiencies of the individual barcoding reactions may be different. Nevertheless, the identifiers are useful if the output of one sequencing lane is greater than required by a single sample. True thread reads corresponded to 99.3%, 98.3% and 85.5% of the reads for the EFO-21 RNA dilution series ([Table 1](#t1){ref-type="table"}). Correspondingly, for SK-MEL-30 these percentages were 98.9%, 94.2% and 59.9%.

Next, we sought to investigate whether the different oligonucleotide:RNA ratios affected or skewed the obtained expression data. To this end, we calculated all possible pairwise Pearson correlation coefficients between the reactions employing total RNA from the same cell line ([Table 2](#t2){ref-type="table"}). The obtained true thread counts were used as input in this analysis. Overall, a high level of correlation was observed. For EFO-21 the correlations between the highest total RNA amount (350 ng) and the dilutions were 0.98 for the 35 ng and 0.93 for the 3.5 ng samples, respectively. The analogous coefficients for SK-MEL-30 were 0.97 and 0.90. Accordingly, reduction of input total RNA and, consequently, altered oligonucleotide:RNA ratios did not significantly change the generated expression profiles. Thereafter, expression data generated by the TnT-454 and TnT-array approaches was compared. Generally, a high level of correlation was observed for the total RNA of 350 and 35 ng, respectively (data not shown). The highly abundant transcripts were the same with both detection approaches. Equally, there was congruency with respect to lowly expressed genes. However, the array platform generated low signals for the lowest input total RNA (3.5 ng). Taken together, we conclude that both readout platforms -- massively parallel 454 sequencing and conventional arrays -- produce comparable expression profiles when the concentration of target template is high while the sequencing approach renders reliable results with as low as 3.5 ng of total RNA.

To further validate the TnT-454 strategy, three genes exhibiting diverse expression behaviour between the two analyzed cell lines in the sequencing data were studied with the established RT-PCR method. One of the genes -- DCT -- was found to be expressed in SK-MEL-30, but was not detected in EFO-21. APLP1 displayed an inverse profile with expression in EFO-21, but not in SK-MEL-30. Finally, expression of LAMB1 was observed in both cell lines. The RT-PCR results displayed good accordance with the TnT-454 profiles (data not shown). As such, the TnT-454 method is a viable and reliable means of measuring abundance levels of selected transcripts.

Having established that the sequencing-based readout of TnT reactions does produce dependable expression profiles, we next turned our attention to undesired products. These were defined as reads mapping to two potential DNA threads with alignment characteristics above a pre-defined threshold (see Methods). The fractions of such undesired entities were 0.7%, 1.7% and 14.5% for the EFO-21 reactions employing 350 ng, 35 ng and 3.5 ng total RNA, respectively ([Table 1](#t1){ref-type="table"}). For SK-MEL-30, the analogous percentages were 1.1%, 5.8% and 40.1% ([Table 1](#t1){ref-type="table"}). Importantly, although the fraction of undesired products increases as the input material entering the pipeline is reduced, it does not significantly affect the generated expression data, as evidenced by the \>0.90 Pearson correlation coefficients between samples featuring different total RNA amounts ([Table 2](#t2){ref-type="table"}). Accordingly, the undesired products do not skew the obtained expression profiles.

Nevertheless, the side products warrant further attention as they have the potential to consume valuable reagents and use up sequencing resources. To gain insight into the creation of undesired entities, the most occurring side products were extracted from the sequencing data and analyzed. In this analysis, the reactions encompassing 3.5 ng of input material were considered. Five species correspond to the majority of the non-informative reads. For EFO-21 three species account for 95.0% of the undesired reads (BCL2L2-SCD5: 55.8%, SLC2A1-FADS1: 31.0% and S100A8-JUN 8.2%). In the case of SK-MEL-30, four species make up for 95.7% of the undesired products (BCL2L2-SCD5: 81.7%, SOX4-MYC: 6.7%, AQP3-DMKN 3.7% and S100A8-JUN 3.6%). Clearly, the product formed by the extension primer of BCL2L2 and thread-joining primer of SCD5 is the main culprit. This undesired entry entails side-by-side ligation of the above-mentioned TnT primers. However, there is not any apparent molecule able to prime this ligation event. The same pattern is observed for the extension primer of SLC2A1 and thread-joining primer of FADS1, as well as the extension primer of AQP1 and thread-joining primer of DMKN. These three species are most probably formed in the trinucleotide threading reaction, making use of yet unidentified molecules for enabling of the ligation. A considerable amount of effort was used during TnT primer design to ascertain that no transcript, complete and/or partial thread could be able to join two mismatching TnT primers, but the presence of such priming molecules cannot be fully excluded. The fourth undesired moiety comprises the extension primer of S100A8 and the thread-joining primer of JUN with a single C base in-between. This structure is most likely also generated in the threading reaction, once again employing an unknown molecule responsible for bringing the two primers in close proximity. On the other hand, the SOX4-MYC moiety encompasses thread-joining primers of SOX4 and MYC and requires the reverse complement of one of the probes. Accordingly, it is created in the PCR amplification step. By employing an alternative clean-up strategy as presented in the Discussion section it could be eliminated.

Discussion
==========

Gene expression analysis with trinucleotide threading (TnT) is capable of profiling abundance levels of intermediate transcript sets and, accordingly, complements comprehensive methods targeting the entire transcriptome and single-gene validation approaches. In a proof-of-concept investigation, TnT was shown to accurately monitor expression levels for an 18-gene set (15 targeted genes and 3 housekeeping genes), with the data correlating well to that of the established RT-PCR technology[@b15]. The reliance upon both a polymerase, acting on a restricted trinucleotide set, and a ligase in the TnT process lends the method a high level of specificity. In particular, to generate a spurious DNA thread, not only do the TnT primers need to misanneal, but the created gap must also consist of only three types of nucleotides. In the vast majority of incorrect priming events, the gap will require the full repertoire of nucleotides to be bridged. Accordingly, the elongation will stop when the fourth nucleotide is encountered, precluding formation of a complete thread structure. Such partial threads are discriminated against in the ensuing PCR amplification.

Our previous study entailed an array-based readout where a DNA thread-specific primer extension step was followed by hybridization of the extended primer on universal tag arrays. While generating expression data showing good concordance with RT-PCR, this detection strategy is not capable of revealing if any spurious products were formed during the TnT reaction. This is because unwanted products -- the formation of which is severely hampered as outlined above -- are unable to participate in the primer extension reaction and are thus invisible on the array.

To study the spurious products of the TnT reaction, the TnT gene expression protocol was adapted to readout with massive parallel 454 sequencing. As all generated species are sequenced, a comprehensive view of both the desired and undesired products can be obtained. A set comprising 32 genes was targeted and reliable expression data was generated starting from as low as 3.5 ng of total RNA. The combination of TnT and 454 sequencing produced reliable data as demonstrated by the good correlation with both RT-PCR and TnT read out on conventional arrays. Moreover, by using 350 ng of total RNA as input, undesired products correspond to only 0.7% to 1.1% of the total passed-filter reads, allowing the majority of sequencing resources to be allocated to acquisition of expression data. When lowering the input material amount the fraction of the undesired products increases. However, this does not influence the obtained expression profiles.

Recently, the RASL technique (RNA-mediated oligonucleotide annealing, selection and ligation) for targeted expression analysis, originally relying on array detection, was combined with massively parallel sequencing[@b10][@b11]. While the RASL-seq protocol recommends an input material amount of 1 μg total RNA, random ligation, defined as the ligation of oligonucleotides targeting different genes, is observed with a frequency of about 10%[@b11]. When starting with low amounts or degraded RNA, the random ligation in RASL can exceed 30%[@b11], meaning that a substantial portion of the available resources is allocated to the unspecific products. As mentioned above, 350 ng of the material entering the TnT reaction leads to between 0.7 and 1.1% of undesired products. Lowering the starting amount tenfold still gives percentages well below 10% (observed percentages of 1.7% and 5.8%). Only when starting with 3.5 ng do the percentages reach above 10%. It should, nevertheless, be emphasized that even these high undesired product fractions do not skew the obtained expression data.

The higher occurrence of unspecific products with increased oligonucleotide:RNA ratios can most likely be attributed to an overabundance of TnT primers relative to template transcript molecules. When the number of cDNA molecules (the DNA thread-formation promoting species) is reduced, the probability of primer molecules encountering other primer molecules instead of the intended targets is increased. This translates into a higher potential for spurious primer interactions. During the exponential PCR amplification these primer products may outcompete the desired DNA threads. Furthermore, there is always a certain level of "primer noise" independent of the input of total RNA. However, this noise becomes more pronounced with lowered input total RNA. Taken together, to minimize the creation of resource-consuming side products it is of significance to select a balanced oligonucleotide:RNA ratio, where the reaction primers are more likely to interact with their correct partners than amongst themselves.

The situation is further aggravated in the current TnT setup. To increase sensitivity, the threading reaction is cycled allowing each target molecule to generate several DNA threads in a linear amplification. This enables a reduction in input material, but simultaneously gives the TnT oligonucleotides additional possibilities for undesired interactions. This issue could be addressed by reducing the number of TnT cycles. Also, all TnT oligonucleotides are carried over to the PCR amplification, lending these further opportunities to act in an undesired manner. However, by implementing a clean-up step the primers can be removed prior to the PCR. For example, by biotinylating the extension TnT primer instead of the oligo dT used to prime first-strand cDNA synthesis, a streptavidin-coated magnetic beads purification scheme eliminating all thread-joining primers and ultimately leading to cleaner amplification reactions can be envisioned.

In this investigation, 454 was the platform of choice. This platform generates long reads but the total number of sequences is rather small. To improve the dynamic range, the TnT approach would benefit from an increased number of reads. Fortunately, the size of the DNA threads is matched to platforms offered by Illumina and Life Technologies that produce several billion reads. Accordingly, these systems may be preferable. The 454 platform was chosen due to its availability.

The prices associated with massively parallel sequencing, although steadily dropping, are still rather steep and thus less than optimal for smaller studies. In addition, current sequencing instruments suffer from poor granularity as they are run in an 'all-or-none'-fashion. This implies that the number of reads generated even from a single sequencing lane far exceeds what is necessary to profile small- or moderately-sized gene sets. This could be resolved by, for example, increasing the multiplexity of the TnT reaction, i.e. to target more genes simultaneously. TnT is a scalable method and has been used to genotype 147 SNPs in parallel. Ongoing studies aim to increase this more than 10-fold. Moreover, a barcoding scheme can be employed for individual and unique labelling, allowing a large number of samples to be pooled and sequenced in the same lane and deconvoluted post-sequencing using the barcode. Recently, in our lab a combinatorial two-tag strategy was implemented to label 5000 samples, allowing these to be processed concurrently[@b16]. Furthermore, several commercial vendors have introduced more economical sequencing instruments with reduced output that are more suited to smaller research projects and diagnostic applications. The MiSeq offered by Illumina and the Ion Torrent PGM system (Life Technologies) are two examples of such instruments.

Taken together, we envision TnT in conjunction with sequencing technologies to reliably and conveniently profile user-selected gene sets across numerous samples starting from low total RNA amounts. This therefore represents a targeted RNA-Seq strategy.

Methods
=======

Genes and probes
----------------

32 genes implicated in basal cell carcinoma were selected ([Table 3](#t3){ref-type="table"}). The design of the two TnT probes -- the extension primer and the thread-joining primer -- was performed using a custom script implemented in Java/BioJava ([Table 3](#t3){ref-type="table"})[@b15]. As oligo dT was used to initiate cDNA synthesis, TnT regions in 3′-parts of mRNAs were favoured. 10--12 bp extension regions were used (14 bp in one instance). A NCBI BLAST-search against the 'human genomic plus transcript' database (Build 36.3) was performed for each complete DNA thread (extension primer -- extension region -- thread-joining primer) to avoid the inclusion of DNA threads with several highly scoring hits to the genome and/or transcriptome. Additionally, the NCBI nucleotide database was used to scan the DNA threads for SNPs to eliminate the risks of inefficient annealing.

The detection oligonucleotides for the direct hybridization of the TnT products to microarrays were designed using a custom Perl/BioPerl script ([Table 4](#t4){ref-type="table"}). The script converts the input of complete DNA threads to a list of oligonucleotides complementary to the extension regions and the necessary flanking bases. Each of these oligonucleotides carried a 5′-Amino C6 group modification and a 15T spacer.

Probe sets for five of the genes (d02, d08, u01, u05 and u19) were ordered from Eurofins MWG Operon (Ebersberg, Germany). The remaining sets were synthesized by Thermo Fisher Scientific (Ulm, Germany). The thread-joining primers were ordered with 5′-phosphate groups. The necessary universal amplification primers were acquired from Eurofins MWG Operon ([Table 3](#t3){ref-type="table"}).

Total RNA, cDNA synthesis and purification
------------------------------------------

The employed total RNA originated from two human cell lines: EFO-21 (ovaries, serous cystadenocarcinoma) and SK-MEL-30 (skin, malignant melanoma).

Total RNA was diluted 100 times in a two-step series, each step diluting the sample 10-fold, with DEPC-treated water. The diluted samples were subsequently used as template for cDNA synthesis, with the individual reactions encompassing 2 μg, 200 ng and 20 ng total RNA, respectively. Firstly, the total RNA was combined with 0.7 nmol of biotinylated oligo dT (5′-BioTEG-T~20~-V; Qiagen Operon, Huntsville, AL, USA) and dNTPs. This mixture was incubated at 70°C for 10 minutes followed by 4°C for 4 minutes. 200 units of SuperScript III reverse transcriptase (Invitrogen, Carlsbad, CA, USA) were added and the reaction placed at 46°C for 60 minutes followed by 85°C for 15 minutes. The 20 μl cDNA synthesis reaction comprised 35 μM oligo dT, 0.5 mM of each dNTP and 5 mM DTT (Invitrogen) in 1x first-strand buffer (50 mM Tris-HCl pH 8.3, 75 mM KCl and 3 MgCl~2~; Invitrogen).

Biotinylated cDNA (½ of the reaction was purified, corresponding to 1 μg, 100 ng and 10 ng of total RNA, respectively) was captured on streptavidin-coated superparamagnetic beads. This was performed in a Magnatrix 1200 biomagnetic workstation (NorDiag AB, Hägersten, Sweden) employing a custom protocol[@b15]. Briefly, 30 μl Dynabeads M-270 Streptavidin (equalling approximately 20×10^6^ beads; Invitrogen) were introduced, the biotinylated cDNA immobilized at room temperature for 15 minutes and the beads collected and washed. Lastly, the bound cDNA was released by suspending the beads in pure water and raising the temperature to 80°C for 1 s[@b18].

Trinucleotide threading
-----------------------

The 10 μl trinucleotide reaction included an amount of cleaned-up cDNA corresponding to either 350 ng, 35 ng and 3.5 ng of total RNA, 0.01 nM of each extension primer, 0.05 nM of each thread-joining primer, 0.2 mM of the ACG trinucleotide mix (0.2 mM each of dATP, dCTP and dGTP), 2 units of Ampligase DNA ligase (Epicentre Biotechnologies, Madison, WI, USA) and 1 unit of AmpliTaq DNA polymerase Stoffel fragment (Applied Biosystems, Foster City, CA, USA) in 1x Ampligase reaction buffer (20 mM Tris-HCl pH 8.3, 25 mM KCl, 10 mM MgCl~2~, 0.5 mM NAD, and 0.01% Triton X-100; Epicentre). The reaction was cycled with the following parameters: 20°C for 5 min, 95°C for 5 min, 99 cycles of 95°C for 15 s and 63°C for 12 min. Compared to the previously published TnT protocol[@b15], the primer amount was reduced 1000-fold. This was done as the original conditions resulted in a considerable fraction of primer-dimers as the input RNA was reduced (data not shown).

The cDNA was eliminated from the mixture by immobilization on 15 μl Dynabeads M-270 Streptavidin (corresponding to about 10×10^6^ beads; Invitrogen) for 30 minutes at room temperature. The supernatant was subjected to PCR, amplifying all DNA threads simultaneously. Each 50 μl amplification harboured 0.2 mM dNTPs, 0.2 μM of each generic primer, 1 unit Platinum *Taq* DNA polymerase (Invitrogen) and 5 mM MgCl~2~ in 50 µl 1x PCR buffer (20 mM Tris-HCl pH 8.4 and 50 mM KCl; Invitrogen). The cycling parameters were: 95°C for 5 min, 30 cycles of 95°C for 30 s, 65°C for 30 s and 72°C for 30 s, and 72°C for 2 min. The PCR reactions were purified with the MinElute PCR purification kit (Qiagen, Hilden, Germany) with elution in 25 μl EB buffer (10 mM Tris-Cl, pH 8.5; Qiagen). The products were validated on a 2100 Bioanalyzer instrument (Agilent Technologies, Santa Clara, CA, USA) with the DNA 1000 Series II kit (Agilent Technologies).

454 sequencing
--------------

The purified and quality assessed samples were enrolled into the single-end amplicon sequencing pipeline for the Genome Sequencer FLX Titanium instrument (Roche Applied Science / 454 Life Sciences, Branford, CT, USA). Standard Multiplex Identifiers (MIDs Roche Applied Science / 454 Life Sciences) were used to be able to pool several samples in each sequencing lane. An automated version of the protocol was utilized for library preparation[@b19].

454 data analysis
-----------------

The 454 data output comprised a FASTA file of all reads that passed the built-in quality filters. The data analysis, resulting in a text file with the number of hits to 'true' DNA threads and to undesired products, was performed with custom Perl/BioPerl scripts. Firstly, the reads were sorted based on their MID sequences. In this step no mismatches in the MID sequences were allowed. Thereafter, a database containing DNA threads of all analyzed genes was set up. Each entry of the MID-sorted output files was BLAST searched against this database. Single hits against theoretical threads with an alignment length of over 47 bases were classified as 'true' threads and counted. Reads mapping to two thread entities (double-hits), indicating a possible amalgamation, were categorized according to the identities of the two matches, counted and the sequences of their reads printed into a separate file. The requirement for inclusion was that the sum of the two highest-ranking alignment lengths was over 40 bases. Reads producing short alignments or giving no hits were removed. Pearson correlation coefficients between different samples were calculated with the R environment using the obtained DNA thread counts.

The most prevalent double-hits were investigated further. The reads were aligned with ClustalW2 using default parameters. The obtained alignments were manually evaluated. Subsequently, the consensus sequence was BLAST-searched against the NCBI 'human genomic plus transcript' database (Build 36.3) employing default parameters.

Array experiments
-----------------

The array fabrication has been previously described[@b15][@b20]. A parallel thread amplification reaction with the conditions described above, but using a Cy3-labeled forward universal amplification primer, was set up to incorporate the dye into the final product. 20 μl of each amplification reaction was combined with 20 μl hybridization buffer (5x SSC with 0.2% SDS). This mixture was heat denatured at 95°C for 30 seconds and introduced to the array. The slide was incubated for 75 minutes at 50°C and 85 rpm shaking. Subsequently, a three step wash procedure was implemented: 50°C 2x SSC with 0.1% SDS for 5 min, 0.2x SSC for 1 min at room temperature and 0.1x SSC for 1 min at room temperature. The slide was dried by centrifugation and scanned with an Agilent G2505B scanner (Agilent). The images were analyzed with GenePix Pro 5.1 (Molecular Devices, Sunnyvale, CA, USA).

RT-PCR
------

Three genes exhibiting different expression characteristics in the two analyzed cell lines were further investigated with RT-PCR: DCT (expressed in SK-MEL-30 but not in EFO-21), APLP1 (expressed in EFO-21 but not in SK-MEL-30) and LAMB1 (expressed in both cell lines). To enable a faithful comparison, the primers were designed to cover the TnT regions, or at least partly overlap these ([Table 5](#t5){ref-type="table"}).

Reverse transcription was performed with SuperScript III First-Strand Synthesis System (Invitrogen) following the provided instructions. 50 pmol non-biotinylated oligo-T~23~ (Qiagen Operon) were used. 2 μg of total RNA acted as template. The cDNA was purified with the MinElute PCR Purification Kit (Qiagen) and analyzed with the 2100 Bioanalyzer instrument (Agilent Technologies) using the RNA Pico Series Kit (Agilent Technologies).

Real-time PCR was performed using the iQ SYBR Green Supermix (Bio-Rad Laboratories, Hercules, CA, USA) in an iCycler instrument (Bio-Rad Laboratories). 25 μl reactions were set up according to the manufacturer\'s recommendations. 5 pmol each of the forward and reverse primers were used. The thermal cycling parameters were: 95°C for 3 min followed by 40 cycles of 95°C for 30 s, 55°C for 45 s and 72°C for 45 s. The threshold cycles (*C*~T~) were determined with the iCycler software (version 3.0a; Bio-Rad Laboratories) and compared between the cell lines.
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###### Sequencing statistics and TnT product percentages

                            ***EFO-21***    ***SK-MEL-30***                                                  
  ------------------------ --------------- ----------------- --------------- --------------- --------------- ---------------
  Reads                         34268            29966            53020           82309           51874           51622
  True threads              34019 (99.3%)    29467 (98.3%)    45357 (85.5%)   81368 (98.9%)   48852 (94.2%)   30932 (59.9%)
  Reads with double hits     249 (0.7%)       499 (1.7%)      7663 (14.5%)     941 (1.1%)      3022 (5.8%)    20690 (40.1%)

The number of sequencing reads passing the filters for each of the six libraries is indicated. These reads have passed the 454 quality filters and have given above-threshold values in a BLAST search against a database of all hypothetical threads. Furthermore, the number of true threads and of reads aligning to two hypothetical threads, as well as the corresponding percentages, are shown. Additional information about the data filtering and analysis is provided in the Methods section.

###### Pearson correlation coefficients

                        ***EFO-21***                         ***SK-MEL-30***                                     
  ------- ------------ -------------- ---------- ---------- ----------------- ------------ ---------- ---------- ----------
  *454*    **350 ng**     **1.00**       0.98       0.93          *454*        **350 ng**   **1.00**     0.97       0.90
           **35 ng**                   **1.00**     0.96                       **35 ng**               **1.00**     0.92
           **3.5 ng**                             **1.00**                     **3.5 ng**                         **1.00**

###### Genes and trinucleotide threading (TnT) primers

                                                                          ID        Gene              Accession                Extension primer                                         Thread-joining primer                   
  ------------------------------------------------------------------- ---------- ---------- ----------------------------- --------------------------- ----------------------------- ----------------------------- ---------------------------
  *BCC genes*                                                            d01        AQP3             NM_004925.3           gagctgctgcaccatattcctgaac    GTTACAGTCTTAGGGATCCGGGAT      TTTAGAAAGGGTCGTCACTCCTTTA    gctctgaaggcggtgtatgacatgg
                                                                         d02       PCDH21            NM_033100.1           gagctgctgcaccatattcctgaac     GTAGGCCTCCAGGGAAAGAGCT         TGGCACACTGGGCAGGCTTGC      gctctgaaggcggtgtatgacatgg
                                                                         d03       FCGBP             NM_003890.2           gagctgctgcaccatattcctgaac    ATCCACCAGGAACGAAGATTTCCT       TGGTCCCTCTGGAGGTTGCAGT      gctctgaaggcggtgtatgacatgg
                                                                         d04      C19orf57           NM_024323.3           gagctgctgcaccatattcctgaac     CTCCAGGAAGCTGGCCACCTCT       TCCTGTCCGGATTTGCAAATTTTAG    gctctgaaggcggtgtatgacatgg
                                                                         d06        DMKN     NM_033317.2, NM_001035516.1   gagctgctgcaccatattcctgaac     CCACTGCACTGTGGTGCTTCAGT      TCGTCACATACACCAGCATCTTTC     gctctgaaggcggtgtatgacatgg
                                                                         d07        DCT              NM_001922.2           gagctgctgcaccatattcctgaac     CCTAGGGTGCTCATGCCTTACCT       TGGCCAAGCCACAGTTCTGACG      gctctgaaggcggtgtatgacatgg
                                                                         d08       S100A8            NM_002964.3           gagctgctgcaccatattcctgaac    GCCACAAAGAGTAGCTGAGTTACT       TGGGCCCCTGGACATGTACCTG      gctctgaaggcggtgtatgacatgg
                                                                         d09       LAMB1             NM_002291.2           gagctgctgcaccatattcctgaac    GTTAGAGAGGAATGTGGAAGAACTT       TGCCCAAAACTCCGGGGAGGC      gctctgaaggcggtgtatgacatgg
                                                                         d13       SLC2A1            NM_006516.2           gagctgctgcaccatattcctgaac    CACTGAGGGCCACACTATTACCAT       TGTGGGAGCCTGCAAACTCACTG     gctctgaaggcggtgtatgacatgg
                                                                         d16       APLP1     NM_001024807.1, NM_005166.3   gagctgctgcaccatattcctgaac    CCATCCCTAAGAATTCCCAGATAGT       TCCCCACGTGGCACCTCCTCA      gctctgaaggcggtgtatgacatgg
                                                                       dBCL2L2     BCL2L2            NM_004050.3           gagctgctgcaccatattcctgaac     GGAAACCCCAGAGACTCTTCTGT      TAGGGACTCTCTTCTAGAGCCATA     gctctgaaggcggtgtatgacatgg
                                                                       dCTNNBIP   CTNNBIP1           NM_020248.2           gagctgctgcaccatattcctgaac     CTGGTTAGCTGACAGTCAGCTGT       TACAACCCTACCCTGGCAGGGA      gctctgaaggcggtgtatgacatgg
                                                                        dFADS      FADS1             NM_013402.3           gagctgctgcaccatattcctgaac     ATGGCCACAAAGGGACACACAGT     TCGGAATGTTACAATGGTAAAATGAG    gctctgaaggcggtgtatgacatg
                                                                       m1 LEF1      LEF1             NM_016269.2           gagctgctgcaccatattcctgaac    CTCTTCTGGAGATGGAAGCTTGTT        TGTCTCCACGGCCTGCCCAGT      gctctgaaggcggtgtatgacatgg
                                                                        m2 MYC      MYC              NM_002467.3           gagctgctgcaccatattcctgaac    GTTGCGGAAACGACGAGAACAGTT      TTGAACAGCTACGGAACTCTTGTG     gctctgaaggcggtgtatgacatgg
                                                                       m4 GLI1      GLI1             NM_005269.1           gagctgctgcaccatattcctgaac     TGAGTCCTCCTCCTTCCCATGAT       TCTGGACATACCCCACCTCCCT      gctctgaaggcggtgtatgacatgg
                                                                       m6 CSTA      CSTA             NM_005213.3            gctgctgcaccatattcctgaac    ATGCACTTGAAAGTATTCAAAAGTCTT    TGAGGACTTGGTACTTACTGGATAC    gctctgaaggcggtgtatgacatgg
                                                                         u01      TACSTD1            NM_002354.1           gagctgctgcaccatattcctgaac    ACACAAATTACAAATGTGTGTGCGT     TCTTTGAAGGTCATGAGTTTGTTAG    gctctgaaggcggtgtatgacatgg
                                                                         u02        NPNT           NM_001033047.1          gagctgctgcaccatattcctgaac    AAGGTCTTCTGTCATTTAACCTGGT    TGGAGGGGGAAAATAAATCATTAAGC    gctctgaaggcggtgtatgacatg
                                                                         u04        SCD5           NM_001037582.2          gagctgctgcaccatattcctgaac    CTCGTTTTGTGTCCTGAGCCCTAT     TTATAAATCATGCCTGTTTAGATGTTT    gctctgaaggcggtgtatgacat
                                                                         u05        BNC2             NM_017637.5           gagctgctgcaccatattcctgaac    AGGAAAGACCAAAAGTATTTGCAGT    TATATCAAACACTATGTTAAATGACAA    gctctgaaggcggtgtatgacat
                                                                         u06        SOX4             NM_003107.2           gagctgctgcaccatattcctgaac    CAGAGGCTTTAAAACTGGTGCAATT    TTCTGTAGCTTTAACTTGTAAACCAC    gctctgaaggcggtgtatgacatg
                                                                         u07       MON1B             NM_014940.2           gagctgctgcaccatattcctgaac    GGTTGTAGCATGTGTGCTGGCAAT       TGTGTTCTGCGCCTGCCCAGAG      gctctgaaggcggtgtatgacatgg
                                                                         u09      IGF2BP2          NM_001007225.1          gagctgctgcaccatattcctgaac    AGCTGTTCTGAATTGTCTTCCGCT      TATATGGCCTTCTTTTGGACAAACC    gctctgaaggcggtgtatgacatgg
                                                                         u14        FZD8             NM_031866.1           gagctgctgcaccatattcctgaac     TGACTTACCCTGGAGGAGGGGT        TGATGGGATTGCACGGTTTGGGT     gctctgaaggcggtgtatgacatgg
                                                                         u15      C1orf117           NM_182623.2           gagctgctgcaccatattcctgaac      CACCTGCTCCCCGGCTCTCTT        TCTGTCTCTCTGGAGTGTCTGTC     gctctgaaggcggtgtatgacatgg
                                                                         u19       PPAP2B     NM_177414.1, NM_003713.3     gagctgctgcaccatattcctgaac    TTCGTGTCTGACCTCTTCAAGACT        TCTCCCTGCCTGCCCCTGCTA      gctctgaaggcggtgtatgacatgg
                                                                         u20       PLCE1             NM_016341.3           gagctgctgcaccatattcctgaac    GGGCTGGGGGCCATAAAATATGTT      TTCTGCCATTGTAGTGCAAAAGCAG    gctctgaaggcggtgtatgacatgg
                                                                        uCHGA       CHGA             NM_001275.3           gagctgctgcaccatattcctgaac      GCAGGCACTACGGCGGGGCT          TGGCAGGGCTGGCCCCAGGG       gctctgaaggcggtgtatgacatgg
                                                                        uGLI2       GLI2             NM_005270.3           gagctgctgcaccatattcctgaac     TCCTTCTGCCCGCTGAGTCACT       TGATGACATGTGTAGGTGGTGTGG     gctctgaaggcggtgtatgacatgg
                                                                         uJUN       JUN              NM_002228.3            gctgctgcaccatattcctgaac    AGAAATTTTACAATAGGTGCTTATTCT   TTGGTGGCAGATTTTACAAAAGATGT    gctctgaaggcggtgtatgacatg
                                                                        uPTCH      PTCH1             NM_000264.3           agctgctgcaccatattcctgaac    ACCTGACCCTATTTTTGTTTTCTCAT    TTCCTAAGTTAACCATCAAAATTAGTC    gctctgaaggcggtgtatgacat
  Forward universal amplification primer: gagctgctgcaccatattcctgaac                                                                                                                                               
  Reverse universal amplification primer: ccatgtcatacaccgccttcagagc                                                                                                                                               
  Labeled forward universal primer: Cy3-gagctgctgcaccatattcctgaac                                                                                                                                                 
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The project ID, official symbol and accession number is provided for each of the 32 genes. All primer sequences are written from 5′ to 3′. The universal amplification tag sequences are depicted in lowercase letters and the gene-specific regions in capital letters. Apart from a 5′-phosphate on the thread-joining primers the probes were unmodified.

###### Detection oligonucleotides

  ID            Gene        Detection primer
  ---------- ---------- -------------------------
  d01           AQP3       AAAGTGGGGTCTCCCATC
  d02          PCDH21      CCATTCCTGCCTCCCAGC
  d03          FCGBP      GACCAGGTCTTCTTCAGGAA
  d04         C19orf57     GGATGGGCCCTGCTCAGA
  d06           DMKN        CGAGGCTGGTGGCCACT
  d07           DCT        CCAGCCTCTTCTCTTAGG
  d08          S100A8       CAGCCTCTGGGCCCAG
  d09          LAMB1       GGCAGCTTTCCGCTTAAGT
  d13          SLC2A1      ACAGGCCCTCTTCTCATG
  d16          APLP1       GGGAGGCTGCTGGGACTA
  dBCL2L2      BCL2L2     CCCTAGTTTTCCCTGACAGA
  dCTNNBIP    CTNNBIP1     GTAGCTGTGTTCCCCACA
  dFADS        FADS1       CCGAGCCTTTTGTCACTG
  m1 LEF1       LEF1      GACAGTCTGGGTTTTCAACA
  m2 MYC        MYC       TTCAAGTTTGTGTTTCAACTG
  m4 GLI1       GLI1       AGAGCTGCCCCGCTGATC
  m6 CSTA       CSTA       CTCATTTTGTCCGGGAAGA
  u01         TACSTD1      AGATGTCTTCGTCCCACG
  u02           NPNT        CCAGCCCTGCCTTTACC
  u04           SCD5       TAAGGTGGGCTGGCCATA
  u05           BNC2     GATATAGTTTCTTTTGTACTGCA
  u06           SOX4     AGAATCCCTTTTTGCTGTAATT
  u07          MON1B       CACACTGCGGCCCTGATTG
  u09         IGF2BP2      TATAGGTTCTTGGCTAGCG
  u14           FZD8       ATCAGGTGGCGGTCACCC
  u15         C1orf117     CAGATGTCCTGGGTGAAGA
  u19          PPAP2B      GAGAGCGTCGTCTTAGTC
  u20          PLCE1      AGAATTGGGTGGTTGCAACA
  uCHGA         CHGA        CCAGCCGGTGTCTCAGC
  uGLI2         GLI2      CATCATTCTCTGCCCAGTGA
  uJUN          JUN       ACCAATTCCTGCTTTGAGAAT
  uPTCH        PTCH1      AGGAAGTTTCTTGGTATGAG

All sequences are shown 5′ to 3′. The 5′-end of each detection oligonucleotide carried a C6 amino group and a 15T spacer.

###### RT PCR primers

  ID     Gene        Forward primer           Reverse primer
  ----- ------- ------------------------ -------------------------
  d07     DCT     TAGGGTGCTCATGCCTTACC    CAACTCAAGAAGGAACAGTGAGG
  d09    LAMB1   AGCGAGTTAGAGAGGAATGTGG    CTTCTGCACTTTGCTTCACAG
  d16    APLP1    TCACACCCTTTTGTGAGACG     GAGGCTGCTGGGACTATCTG

All sequences are written from 5′ to 3′.
